Skip to main content

Effectiveness of IL-6 Receptor Inhibitors versus Methotrexate or any Conventional Immunomodulators in Patients with Steroid Refractory Polymyalgia Rheumatica

  • Sponsored by Sanofi
File
(3.38 MB)
×